AFP and hepatocellular carcinoma: On average, people with cirrhosis undergoing 6-monthly US surveillance would experience 17.6 surveillance events over their lifetime and have average total surveillance-, cirrhosis-, and HCC-related costs of $136,324 (2023 AUD), a 5.6% increase compared with to those who do not undergo surveillance, with similar increases with the addition of AFP.